Surging NewLink Genetics Corporation (NLNK) Can't Shake Skeptics

Option bears aren't sold on rallying NewLink Genetics Corp (NLNK)

May 5, 2015 at 11:54 AM
facebook twitter linkedin


solid turn in the earnings confessional has shares of NewLink Genetics Corp (NASDAQ:NLNK) sitting 5.2% higher at $47. Year-over-year, the shares have now advanced an impressive 117%, and continue to find support atop their 100-day moving average. However, one group of options traders isn't buying the hype.

Taking a quick step back, NLNK puts are crossing at six times the usual intraday clip. Most active by far is the May 44 put, where new contracts are being purchased. In other words, these option bears think the biopharmaceutical stock will retreat below $44 by next Friday's close -- when front-month contracts expire.

This pessimism is par for the course. During the past 10 weeks at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), NLNK has amassed a put/call volume ratio of 0.54, which rests just 2 percentage points from a 12-month peak. Given the stock's outstanding technicals, a portion of these long puts -- especially at out-of-the-money strikes -- may have been initiated by shareholders seeking downside protection.

Echoing the aforementioned put-bias is NewLink Genetics Corp's (NASDAQ:NLNK) Schaeffer's put/call open interest ratio (SOIR) of 0.73, which ranks in the 88th percentile of its annual range. In other words, short-term puts outnumber calls by a bigger-than-usual margin, among options expiring in the next three months.
 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Master Portfolio Trial
 


 


 
Special Offers from Schaeffer's Trading Partners